| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1017604954 |
| P356 | DOI | 10.1186/1748-717X-6-49 |
| P932 | PMC publication ID | 3120676 |
| P698 | PubMed publication ID | 21575175 |
| P50 | author | Hirokazu Nagawa | Q114207374 |
| P2093 | author name string | Joji Kitayama | |
| Eiji Sunami | |||
| Koji Yasuda | |||
| Takako Nirei | |||
| P2860 | cites work | Type, density, and location of immune cells within human colorectal tumors predict clinical outcome | Q28131662 |
| Immunosuppressive networks in the tumour environment and their therapeutic relevance | Q29619244 | ||
| Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy | Q29619961 | ||
| Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer | Q29620068 | ||
| Dynamic T(1) mapping predicts outcome of chemoradiation therapy in primary rectal carcinoma: sequence implementation and data analysis | Q33295508 | ||
| Circulating lymphocyte number has a positive association with tumor response in neoadjuvant chemoradiotherapy for advanced rectal cancer | Q33952083 | ||
| Preoperative versus postoperative chemoradiotherapy for rectal cancer | Q34552041 | ||
| Chemotherapy with preoperative radiotherapy in rectal cancer | Q34570877 | ||
| Temporal patterns of fatigue predict pathologic response in patients treated with preoperative chemoradiation therapy for rectal cancer | Q34961213 | ||
| Role of radiotherapy with surgery for T3 and resectable T4 rectal cancer: evidence from randomized trials | Q36386073 | ||
| Sensors of ionizing radiation effects on the immunological microenvironment of cancer | Q36939594 | ||
| Radiation-induced CXCL16 release by breast cancer cells attracts effector T cells. | Q36983211 | ||
| High Ki67, Bax, and thymidylate synthase expression well correlates with response to chemoradiation therapy in locally advanced rectal cancers: proposal of a logistic model for prediction | Q37269734 | ||
| Biomarkers for response to neoadjuvant chemoradiation for rectal cancer | Q37500747 | ||
| Systemic effects of local radiotherapy | Q37539309 | ||
| Radiation-induced IFN-gamma production within the tumor microenvironment influences antitumor immunity | Q40010222 | ||
| Effect of host immune capability on radiocurability and subsequent transplantability of a murine fibrosarcoma | Q40620394 | ||
| Use of molecular imaging to predict clinical outcome in patients with rectal cancer after preoperative chemotherapy and radiation | Q41848836 | ||
| Inflammatory-type responses after exposure to ionizing radiation in vivo: a mechanism for radiation-induced bystander effects? | Q43796897 | ||
| High numbers of granzyme B/CD8-positive tumour-infiltrating lymphocytes in nasopharyngeal carcinoma biopsies predict rapid fatal outcome in patients treated with curative intent. | Q44218349 | ||
| Tumor-infiltrating lymphocytes and perforation in colon cancer predict positive response to 5-fluorouracil chemotherapy | Q46721130 | ||
| Activated cytotoxic T cells as prognostic marker in Hodgkin's disease. | Q50974532 | ||
| CD3+ cells at the invasive margin of deeply invading (pT3–T4) colorectal cancer and risk of post-surgical metastasis: a longitudinal study | Q56942543 | ||
| Tumor infiltrating T lymphocytes in colorectal cancer: Tumor-selective activation and cytotoxic activity in situ | Q79378344 | ||
| Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer | Q80045507 | ||
| [Correlation of VEGF and Ki67 expression with sensitivity to neoadjuvant chemoradiation in rectal adenocarcinoma] | Q83061641 | ||
| Tumor-infiltrating cytotoxic T cells but not regulatory T cells predict outcome in anal squamous cell carcinoma | Q83895049 | ||
| P921 | main subject | chemoradiotherapy | Q5090613 |
| P304 | page(s) | 49 | |
| P577 | publication date | 2011-05-16 | |
| P1433 | published in | Radiation Oncology | Q2313370 |
| P1476 | title | Density of CD4(+) and CD8(+) T lymphocytes in biopsy samples can be a predictor of pathological response to chemoradiotherapy (CRT) for rectal cancer | |
| P478 | volume | 6 |
| Q55091056 | A comparison of the local immune status between the primary and metastatic tumor in colorectal cancer: a retrospective study. |
| Q39187442 | Are tumor-infiltrating lymphocytes protagonists or background actors in patient selection for cancer immunotherapy? |
| Q46540302 | Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Ca |
| Q36490577 | Association between Chemotherapy-Response Assays and Subsets of Tumor-Infiltrating Lymphocytes in Gastric Cancer: A Pilot Study. |
| Q33615807 | CD8/CD45RO T-cell infiltration in endoscopic biopsies of colorectal cancer predicts nodal metastasis and survival |
| Q41822936 | Characterization of the T cell repertoire by deep T cell receptor sequencing in tissues and blood from patients with advanced colorectal cancer |
| Q26799117 | Control of CD8 T-Cell Infiltration into Tumors by Vasculature and Microenvironment |
| Q47108227 | Density of CD8+ lymphocytes in biopsy samples combined with the circulating lymphocyte ratio predicts pathologic complete response to chemoradiotherapy for rectal cancer |
| Q51757785 | Effect of neoadjuvant chemoradiotherapy on perioperative immune function of patients with locally advanced esophageal cancer |
| Q36062936 | Evaluation of immune cell markers in tumor tissue treated with radioimmunotherapy in an immunocompetent rat colon carcinoma model |
| Q37687506 | Identification of a five B cell-associated gene prognostic and predictive signature for advanced glioma patients harboring immunosuppressive subtype preference |
| Q92538896 | Immune Checkpoints in Circulating and Tumor-Infiltrating CD4+ T Cell Subsets in Colorectal Cancer Patients |
| Q26768531 | Immunological Landscape and Clinical Management of Rectal Cancer |
| Q64055804 | Increased CD8+CD28+ T cells independently predict better early response to stereotactic ablative radiotherapy in patients with lung metastases from non-small cell lung cancer |
| Q97529535 | Intratumoral budding and automated CD8-positive T-cell density in pretreatment biopsies can predict response to neoadjuvant therapy in rectal adenocarcinoma |
| Q64116846 | Local environment in biopsy better predict the pathological response to neoadjuvant chemoradiotherapy in rectal cancer |
| Q36432125 | Low stromal Foxp3+ regulatory T-cell density is associated with complete response to neoadjuvant chemoradiotherapy in rectal cancer |
| Q40568414 | Nodal tumor response according to the count of peripheral blood lymphocyte subpopulations during preoperative chemoradiotherapy in locally advanced rectal cancer. |
| Q64903410 | Potential predictive biomarkers in locally advanced rectal cancer treated with preoperative chemo-radiotherapy. |
| Q47111736 | Prediction of radio-responsiveness with immune-profiling in patients with rectal cancer. |
| Q35083126 | Prediction of the preoperative chemoradiotherapy response for rectal cancer by peripheral blood lymphocyte subsets |
| Q93115621 | Preoperative, biopsy-based assessment of the tumour microenvironment in patients with primary operable colorectal cancer |
| Q60956564 | Recent advances in radiation therapy of pancreatic cancer |
| Q34698158 | Reciprocal Complementation of the Tumoricidal Effects of Radiation and Natural Killer Cells |
| Q99552006 | Standard therapies: solutions for improving therapeutic effects of immune checkpoint inhibitors on colorectal cancer |
| Q52679182 | The Peripheral and Intratumoral Immune Cell Landscape in Cancer Patients: A Proxy for Tumor Biology and a Tool for Outcome Prediction. |
| Q48283608 | The clinical implications of immunogenomics in colorectal cancer: A path for precision medicine. |
| Q49719408 | The significance of tumor-infiltrating lymphocytes before and after neoadjuvant therapy for rectal cancer. |
| Q35929864 | Tumor infiltrating lymphocytes (TILs) before and after neoadjuvant chemoradiotherapy and its clinical utility for rectal cancer |
| Q48529729 | Tumor-infiltrating Lymphocytes Predict the Chemotherapeutic Outcomes in Patients with Stage IV Colorectal Cancer |
| Q98633731 | Tumor-infiltrating lymphocytes predict survival outcomes in patients with cervical cancer treated with concurrent chemoradiotherapy |
| Q56895579 | Tumor-infiltrating lymphocytes, forkhead box P3, programmed death ligand-1, and cytotoxic T lymphocyte-associated antigen-4 expressions before and after neoadjuvant chemoradiation in rectal cancer |
| Q37746144 | Tumour-infiltrating regulatory T cell density before neoadjuvant chemoradiotherapy for rectal cancer does not predict treatment response. |
Search more.